Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  New Frontier Health Corporation    NFH   KYG6461G1064

NEW FRONTIER HEALTH CORPORATION

(NFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

New Frontier Health : Healthcare Announces Appointment of Lawrence Chia to Board of Directors

05/22/2020 | 08:03am EST

New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (UFH), today announced that Mr. Lawrence Chia has been appointed an independent director of the Company's board of directors (the "Board"), effective March 31, 2020.

Mr. Lawrence Chia is currently the CEO of the Samling Group of Companies, which has businesses in automobiles, properties, timber, infrastructure, oil palm, oil, and gas, with operations in a number of countries globally. Prior to joining Samling, Lawrence was previously the CEO of Deloitte China, and was on the Deloitte Touche Tohmatsu Limited (DTTL) Executive Committee based in New York and the DTTL Asia Pacific Executive Committee based in Hong Kong. He also serves as an Independent Non-Executive Director of BC Technology Group Limited, a publicly listed company on the Hong Kong Stock Exchange. Mr. Lawrence is a Chartered Accountant of the Institute of Chartered Accountants in England and Wales and a member of the Hong Kong Institute of Certified Public Accountants.

“On behalf of the Board, I am delighted to welcome Lawrence to the team. His more than 30 years of executive leadership experience in financial advisory and corporate finance in Asia will be a great asset to the continued growth of NFH,” said Mr. Antony Leung, Chairman of NFH. “Furthermore, his appointment reflects our commitment to ensuring that we have a broad mix of skills and perspectives on NFH’s board. We look forward to benefiting from his expertise as we continue to make progress on our long-term strategic growth.”

About New Frontier Health Corporation

New Frontier Health Corporation (NYSE: NFH) is the operator of United Family Healthcare (UFH), a leading private healthcare provider offering comprehensive premium healthcare services in China through a network of private hospitals and affiliated ambulatory clinics. UFH currently has nine hospitals in operation or under construction in all four 1st tier cities and selected 2nd tier cities. Additional information may be found at www.nfh.com.cn.

Source: New Frontier Health Corporation


ę Business Wire 2020
All news about NEW FRONTIER HEALTH CORPORATION
02/10NEW FRONTIER HEALTH CORPORATIONá : Announces Receipt of Clarification to Prelimi..
BU
02/10NEW FRONTIER HEALTHá : Receives 'Going-Private' Proposal; Shares Rise
MT
02/10NEW FRONTIER HEALTH CORPORATIONá : Announces Receipt of Preliminary Non-Binding ..
BU
2020NEW FRONTIER HEALTHá : Download PDF PDF Format Download () PDF 6.86 MB
PU
2020NEW FRONTIER HEALTHá : Q3 ()
PU
2020NEW FRONTIER HEALTHá : Fiscal Q3 Loss Narrows Year/Year Amid Revenue Growth; Q4 ..
MT
2020NEW FRONTIER HEALTH CORPORATIONá : Announces Third Quarter 2020 Financial Result..
BU
2020NEW FRONTIER HEALTH CORPORATIONá : to Announce Third Quarter of 2020 Financial R..
BU
2020NEW FRONTIER HEALTHá : Announces Second Quarter 2020 Financial Results
BU
2020NEW FRONTIER HEALTHá : Healthcare to Announce Second Quarter of 2020 Financial R..
BU
More news
Chart NEW FRONTIER HEALTH CORPORATION
Duration : Period :
New Frontier Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEW FRONTIER HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 77,45 CNY
Last Close Price 72,43 CNY
Spread / Highest target 6,93%
Spread / Average Target 6,93%
Spread / Lowest Target 6,93%
EPS Revisions
Managers and Directors
NameTitle
Roberta Lipson Chief Executive Officer & Director
Carl Wu President & Director
Walter Xue Chief Financial Officer
Kam Chung Leung Co-Chairman
Qi Yu Chen Co-Chairman